A startup just raised $22.5M to unblock custom care
Signals InboxAugust 26, 2026MedTech
Hike Medical raised $22.5 million to attack an unglamorous bottleneck in custom medical devices: the workflow between referral, insurance paperwork, clinical documentation, and manufacturing. The thesis is that orthotics and other personalized devices can scale only when the administrative and production layers move together.
We raised $22.5M to fix both halves of the custom medical device supply chain: the paperwork that blocks them and the manufacturing that slows them.
— AB (@bionicaadi) August 25, 2026
In America 🇺🇸, it's easier to prescribe a patient opioids than to get them custom insoles to prevent amputation. Three generations… pic.twitter.com/zWygOdp2Mw
Q1What was actually announced?
Hike founder Aadi Bionica announced the $22.5 million financing, saying the company is fixing both halves of the custom-device supply chain: paperwork that blocks access and manufacturing that slows fulfillment. The financing combines its seed and Series A rounds.
Q2How big is the signal?
The company is targeting orthotics, prosthetics, and other durable medical equipment, where a prescription can trigger authorizations, documentation, measurements, production, and reimbursement steps. The round is large for an early workflow company because it is also tackling physical manufacturing, not only software.
Q3Why does it matter now?
Custom devices can prevent expensive downstream complications, but clinics often lose time to fragmented referrals and reimbursement. AI can extract documentation and automate handoffs, while digital manufacturing can shorten production. If both improve together, the economic value comes from faster patient throughput and fewer abandoned orders.
Q4What is the catch?
Healthcare workflow automation still has to survive payer rules, clinical accuracy requirements, and messy integrations. Manufacturing custom devices adds another source of operational risk. Hike must prove that automation lowers total cost without turning nuanced clinical decisions into a rigid software process.
Q5What should we watch next?
Watch fulfillment time, approval rates, number of clinics and device categories, and whether Hike can document fewer denials or amputations rather than only faster paperwork. Expansion into additional custom devices would show the platform is broader than a single orthotics workflow.